Spots Global Cancer Trial Database for therapeutic conventional surgery
Every month we try and update this database with for therapeutic conventional surgery cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Oral CDB-4124 vs. Placebo in Stage I-II Primary Breast Cancer | NCT01800422 | Stage IA Breast... Stage IB Breast... Stage II Breast... | telapristone ac... placebo therapeutic con... laboratory biom... questionnaire a... | 18 Years - | Northwestern University | |
| Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site | NCT05110781 | Locally Advance... Resectable Cuta... Stage III Cutan... | Atezolizumab Radiation Thera... Therapeutic Con... | 18 Years - | University of California, Davis | |
| Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer | NCT04721132 | Resectable Hepa... Stage I Hepatoc... Stage IA Hepato... Stage IB Hepato... Stage II Hepato... | Atezolizumab Bevacizumab Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer | NCT00118040 | Recurrent Bladd... Stage I Bladder... Stage II Bladde... Stage III Bladd... | Genistein Laboratory Biom... Pharmacological... Placebo Adminis... Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer | NCT01100489 | Ductal Breast C... Estrogen Recept... Estrogen Recept... HER2-negative B... HER2-positive B... Invasive Ductal... Invasive Lobula... Male Breast Can... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Progesterone Re... Stage I Breast ... Stage II Breast... Tubular Ductal ... | external beam r... questionnaire a... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center | |
| IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3 | NCT03267680 | Cervical Squamo... Vulvar High Gra... | Cyclophosphamid... Indomethacin IRX-2 Laboratory Biom... Multivitamin Omeprazole Placebo Therapeutic Con... | 25 Years - | University of Southern California | |
| Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer | NCT02827877 | HER2 Positive B... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Copper Cu 64-DO... Laboratory Biom... Pertuzumab Positron Emissi... Therapeutic Con... Trastuzumab | 18 Years - | City of Hope Medical Center | |
| Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma | NCT03197506 | Glioblastoma Gliosarcoma Supratentorial ... | External Beam R... Laboratory Biom... Pembrolizumab Radiation Thera... Temozolomide Therapeutic Con... | 18 Years - | Mayo Clinic | |
| Stereotactic Radiosurgery in Treating Patients With Brain Metastases | NCT00811655 | Metastatic Canc... Unspecified Adu... | therapeutic con... stereotactic ra... | 18 Years - | Duke University | |
| Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer | NCT04759911 | Malignant Thyro... Poorly Differen... Recurrent Thyro... Thyroid Gland A... Thyroid Gland M... Thyroid Gland P... Thyroid Gland S... | Quality-of-Life... Questionnaire A... Selpercatinib Therapeutic Con... | 12 Years - | M.D. Anderson Cancer Center | |
| Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors | NCT00521118 | Complete Hydati... Non-Metastatic ... Partial Hydatid... | Laboratory Biom... Therapeutic Con... | - | GOG Foundation | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ | NCT04144023 | Breast Ductal C... | Granulocyte-Mac... Multi-epitope H... Therapeutic Con... Echocardiograph... Biospecimen Col... Biopsy | 18 Years - | Mayo Clinic | |
| Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery | NCT00835679 | Liver Metastase... Mucinous Adenoc... Mucinous Adenoc... Recurrent Colon... Recurrent Recta... Signet Ring Ade... Signet Ring Ade... Stage IV Colon ... Stage IV Rectal... | cetuximab dasatinib therapeutic con... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer | NCT04628767 | Renal Pelvis an... | Biopsy Biospecimen Col... Cisplatin Computed Tomogr... Doxorubicin Hyd... Durvalumab Gemcitabine Hyd... Magnetic Resona... Methotrexate Pegfilgrastim Therapeutic Con... Vinblastine Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
| Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer | NCT02186470 | Estrogen Recept... Invasive Ductal... Invasive Ductal... Medullary Ducta... Mucinous Ductal... Papillary Ducta... Progesterone Re... Stage IA Breast... Stage IB Breast... Tubular Ductal ... | accelerated par... intensity-modul... image-guided ra... therapeutic con... | 50 Years - | Ohio State University Comprehensive Cancer Center | |
| Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | NCT02427841 | Pancreatic Aden... Resectable Panc... | Fluorouracil Gemcitabine Image Guided Ra... Intensity-Modul... Laboratory Biom... Nab-paclitaxel Therapeutic Con... | 18 Years - | OHSU Knight Cancer Institute | |
| Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery | NCT01912820 | Adenocarcinoma ... Recurrent Prost... Stage I Prostat... Stage IIA Prost... Stage IIB Prost... Stage III Prost... Stage IV Prosta... | green tea extra... quercetin placebo therapeutic con... laboratory biom... | 40 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery | NCT00667901 | Melanoma (Skin) | riluzole protein express... reverse transcr... western blottin... immunohistochem... laboratory biom... pharmacological... neoadjuvant the... therapeutic con... | 18 Years - | Rutgers, The State University of New Jersey | |
| Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer | NCT00899210 | Colorectal Canc... Metastatic Canc... | laboratory biom... cryosurgery radiofrequency ... therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus | NCT00002706 | Endometrial Ade... Stage I Uterine... Stage I Uterine... Stage II Uterin... Stage II Uterin... | Laparoscopic Su... Quality-of-Life... Therapeutic Con... | 18 Years - | GOG Foundation | |
| Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer | NCT00980460 | PRETEXT I Hepat... PRETEXT II Hepa... PRETEXT III Hep... PRETEXT IV Hepa... | Cisplatin Dexrazoxane Doxorubicin Hyd... Fluorouracil Irinotecan Hydr... Laboratory Biom... Liver Transplan... Temsirolimus Therapeutic Con... Vincristine Sul... | - 21 Years | National Cancer Institute (NCI) | |
| Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma | NCT03197506 | Glioblastoma Gliosarcoma Supratentorial ... | External Beam R... Laboratory Biom... Pembrolizumab Radiation Thera... Temozolomide Therapeutic Con... | 18 Years - | Mayo Clinic | |
| Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic Acid | NCT01409811 | Estrogen Recept... Invasive Ductal... Progesterone Re... Stage IA Breast... Stage IB Breast... Stage IIA Breas... Stage IIB Breas... | zoledronic acid laboratory biom... therapeutic con... | - | City of Hope Medical Center | |
| Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction | NCT00938470 | Adenocarcinoma ... Esophageal Canc... Gastric Cancer | capecitabine docetaxel fluorouracil oxaliplatin radiation thera... therapeutic con... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma | NCT00645632 | Sarcoma | cisplatin doxorubicin hyd... ifosfamide methotrexate adjuvant therap... neoadjuvant the... therapeutic con... | - | Mayo Clinic | |
| Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery | NCT03943173 | BRCA-Mutated Ov... BRCA1 Gene Muta... BRCA2 Gene Muta... High Grade Fall... High Grade Ovar... Primary Periton... Stage III Fallo... Stage III Ovari... Stage III Prima... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIA1 Fal... Stage IIIA1 Ova... Stage IIIA2 Fal... Stage IIIA2 Ova... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar... Stage IVA Fallo... Stage IVA Ovari... Stage IVA Prima... Stage IVB Fallo... Stage IVB Ovari... Stage IVB Prima... | Chemotherapy Olaparib Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Safety of MRI Compatible Hardware for MRI-based Image Guidance During Spine Surgery | NCT04563806 | Thoracic Spine ... | Magnetic Resona... Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL) | NCT04871529 | Bladder Carcino... Infiltrating Re... Stage II Bladde... | Therapeutic Con... Avelumab Gemcitabine Hyd... Carboplatin | 18 Years - | SWOG Cancer Research Network | |
| Dabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D Melanoma | NCT04310397 | Pathologic Stag... Pathologic Stag... Pathologic Stag... | Dabrafenib Spartalizumab Therapeutic Con... Trametinib | 18 Years - | M.D. Anderson Cancer Center | |
| Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery | NCT01854684 | Recurrent Non-S... Stage IIA Non-S... Stage IIB Non-S... Stage IIIA Non-... Stage IIIB Non-... | Temoporfin Therapeutic Con... Photodynamic Th... Laboratory Biom... Pharmacological... | 18 Years - | Roswell Park Cancer Institute | |
| Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
| Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery | NCT01292083 | Recurrent Breas... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage IV Breast... Triple-negative... | azacitidine laboratory biom... immunohistochem... polymerase chai... western blottin... nucleic acid se... therapeutic con... | 18 Years - | University of Southern California | |
| Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer | NCT01212822 | Adenocarcinoma ... Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Squamous Cell C... Stage IA Esopha... Stage IA Gastri... Stage IB Esopha... Stage IB Gastri... Stage IIA Esoph... Stage IIA Gastr... Stage IIB Esoph... Stage IIB Gastr... Stage IIIA Esop... Stage IIIA Gast... Stage IIIB Esop... Stage IIIB Gast... Stage IIIC Esop... Stage IIIC Gast... | bevacizumab oxaliplatin leucovorin calc... fluorouracil therapeutic con... laboratory biom... | 18 Years - | Fox Chase Cancer Center | |
| Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer | NCT03090412 | Stage I Oral Ca... Stage II Oral C... | HPPH Laboratory Biom... Photodynamic Th... Quality-of-Life... Therapeutic Con... | 18 Years - | Roswell Park Cancer Institute | |
| Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma | NCT00822848 | Sarcoma | epirubicin hydr... ifosfamide sorafenib tosyl... immunoenzyme te... immunohistochem... laboratory biom... adjuvant therap... neoadjuvant the... therapeutic con... hypofractionate... | 15 Years - 120 Years | OHSU Knight Cancer Institute | |
| Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma | NCT00742924 | Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide leucovorin calc... methotrexate zoledronic acid adjuvant therap... neoadjuvant the... therapeutic con... filgrastim Mesna | - 40 Years | Children's Oncology Group | |
| Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma | NCT01390571 | Brain and Centr... | olaparib temozolomide gene expression... protein express... laboratory biom... pharmacological... diffusion-weigh... dynamic contras... therapeutic con... | 18 Years - | Cancer Research UK | |
| Combination Chemotherapy, Radiation Therapy, and Sargramostim Before and After Surgery in Treating Patients With Soft Tissue Sarcoma That Can Be Removed By Surgery | NCT00652860 | Metastatic Canc... Sarcoma | aerosol sargram... sargramostim cisplatin doxorubicin hyd... ifosfamide mitomycin C flow cytometry immunological d... laboratory biom... adjuvant therap... multimodality t... neoadjuvant the... therapeutic con... intraoperative ... selective exter... | 18 Years - | Mayo Clinic | |
| Pembrolizumab With or Without Chemotherapy Before Surgery in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer | NCT04061590 | Lung Non-Small ... Stage I Lung Ca... Stage IA1 Lung ... Stage IA2 Lung ... Stage IA3 Lung ... Stage IB Lung C... Stage II Lung C... Stage IIA Lung ... Stage IIB Lung ... Stage IIIA Lung... | Cisplatin Pembrolizumab Pemetrexed Pemetrexed Diso... Therapeutic Con... | 18 Years - | University of California, San Francisco | |
| Loop Resectoscope in Treating Patients With Bladder Cancer or Benign Prostatic Hyperplasia Who Are Undergoing Transurethral Resection | NCT00303654 | Bladder Cancer | biopsy therapeutic con... | - | National Cancer Institute (NCI) | |
| Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor | NCT00352534 | Stage I Kidney ... Stage II Kidney... Stage III Kidne... | 3-Dimensional C... Biospecimen Col... Chest Radiograp... Computed Tomogr... Dactinomycin Doxorubicin Hyd... Echocardiograph... Magnetic Resona... Therapeutic Con... Ultrasound Imag... Vincristine Sul... | - 29 Years | Children's Oncology Group | |
| Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer | NCT00450749 | Adenocarcinoma ... Stage I Prostat... Stage II Prosta... Stage III Prost... | placebo therapeutic con... laboratory biom... lycopene | 18 Years - | National Cancer Institute (NCI) | |
| Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery | NCT05046067 | Lung Neoplasm | Computed Tomogr... Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer | NCT00070317 | Cervical Adenoc... Cervical Adenos... Cervical Squamo... Stage I Cervica... | Isosulfan Blue Lymph Node Mapp... Lymphangiograph... Methylene Blue Radionuclide Im... Sentinel Lymph ... Technetium Tc-9... Therapeutic Con... | - | GOG Foundation | |
| Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer | NCT00118040 | Recurrent Bladd... Stage I Bladder... Stage II Bladde... Stage III Bladd... | Genistein Laboratory Biom... Pharmacological... Placebo Adminis... Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| Extent of Breast Cancer and the Role of Pre-Operative Sonography and MRI | NCT02587663 | Ductal Breast C... Stage IA Breast... Stage IB Breast... Stage II Breast... | Contrast-enhanc... Mammography Therapeutic Con... Ultrasonography Ultrasonography Gadolinium | 18 Years - | University of Southern California | |
| Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery | NCT02738606 | Metastatic Colo... Metastatic Mali... Metastatic Mali... Recurrent Color... Resectable Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... | Chemotherapy Laboratory Biom... Metastasectomy Quality-of-Life... Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer | NCT04973683 | Adenoid Cystic ... Metastatic Aden... | AL101 Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer | NCT02827838 | Human Papilloma... Stage I Oral Ca... Stage I Orophar... Stage II Oral C... Stage II Oropha... Stage III Oral ... Stage III Oroph... Stage IVA Oral ... Stage IVA Oroph... Stage IVB Oral ... Stage IVB Oroph... Stage IVC Oroph... | Durvalumab Laboratory Biom... Therapeutic Con... | 18 Years - | Wake Forest University Health Sciences | |
| Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer | NCT01167725 | Colorectal Canc... | bevacizumab cetuximab FOLFIRI regimen FOLFOX regimen capecitabine fluorouracil irinotecan hydr... leucovorin calc... mitomycin C oxaliplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy | NCT01819233 | Ductal Breast C... Invasive Ductal... Invasive Lobula... Lobular Breast ... Recurrent Breas... Stage IA Breast... Stage IB Breast... | Behavioral diet... Therapeutic con... Radiation thera... Counseling inte... Quality-of-life... | 18 Years - | Thomas Jefferson University | |
| Vorinostat Before Surgery in Treating Patients With Triple-Negative Breast Cancer | NCT01695057 | Stage II Breast... Stage IIIA Brea... Triple-negative... | vorinostat therapeutic con... laboratory biom... | 18 Years - | University of Southern California | |
| Stereotactic Radiosurgery in Treating Patients With Brain Metastases | NCT00811655 | Metastatic Canc... Unspecified Adu... | therapeutic con... stereotactic ra... | 18 Years - | Duke University | |
| Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer | NCT01556243 | Breast Cancer | therapeutic con... whole breast ir... | 40 Years - | Alliance for Clinical Trials in Oncology | |
| Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer | NCT03601507 | CDKN2A-p16 Posi... HPV Positive Or... Stage I Orophar... Stage II Oropha... Stage III Oroph... Stage IVA Oroph... | Alpelisib Laboratory Biom... Pharmacodynamic... Therapeutic Con... | - | University of Arizona | |
| Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery | NCT03493425 | Stage III Nasal... Stage IVA Nasal... | Carboplatin Cisplatin Docetaxel Image Guided Ra... Intensity-Modul... Laboratory Biom... Questionnaire A... Therapeutic Con... | 18 Years - | Eastern Cooperative Oncology Group | |
| Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme | NCT01575275 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Recurrent Adult... | aminolevulinic ... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center | |
| Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer | NCT00849186 | Kidney Cancer | sunitinib malat... neoadjuvant the... therapeutic con... | 18 Years - | Roswell Park Cancer Institute | |
| Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal Cancer | NCT01953952 | Stage III Squam... Stage IVA Squam... Tongue Cancer | therapeutic con... intensity-modul... cisplatin quality-of-life... laboratory biom... | 18 Years - | Radiation Therapy Oncology Group | |
| Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer | NCT01857271 | Stage IIIA Non-... Stage IIIB Non-... | Erlotinib Hydro... Therapeutic Con... Laboratory Biom... | 18 Years - | Albert Einstein College of Medicine | |
| Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery | NCT00316862 | Esophageal Canc... | cisplatin irinotecan hydr... therapeutic con... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma | NCT01378481 | Adult Anaplasti... Adult Anaplasti... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Recurrent Adult... | Vorinostat Stereotactic Ra... Laboratory Biom... Pharmacological... Therapeutic Con... | 18 Years - | National Cancer Institute (NCI) | |
| Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy | NCT01009736 | Prostate Cancer | tomato-soy juic... laboratory biom... pharmacological... therapeutic con... | - | Ohio State University Comprehensive Cancer Center | |
| Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection | NCT02437851 | Anal Squamous C... HIV Infection Stage 0 Anal Ca... Stage I Anal Ca... | Therapeutic Con... | 18 Years - | AIDS Malignancy Consortium | |
| Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer | NCT00003994 | Childhood Hepat... Recurrent Child... Stage I Childho... | therapeutic con... cisplatin vincristine sul... fluorouracil amifostine trih... carboplatin | - 21 Years | Children's Oncology Group | |
| Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer | NCT00002852 | Adenocarcinoma ... Adenosquamous C... Bronchoalveolar... Large Cell Lung... Squamous Cell L... Stage IB Non-sm... | paclitaxel carboplatin therapeutic con... | 18 Years - | National Cancer Institute (NCI) | |
| Aminolevulinic Acid in Visualizing a Tumor During Surgery in Patients With Glioblastoma Multiforme | NCT01575275 | Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Recurrent Adult... | aminolevulinic ... therapeutic con... | 18 Years - | Case Comprehensive Cancer Center | |
| High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer | NCT03870529 | Non Small Cell ... Stage I Lung Ca... Stage Ib Lung C... Stage IA Lung C... Stage IIA Lung ... Stage IIIA Lung... | Vitamin A Compo... Therapeutic Con... | 18 Years - | Wake Forest University Health Sciences | |
| Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery | NCT02730546 | Gastric Cardia ... Gastroesophagea... Stage IB Gastri... Stage II Gastri... Stage IIA Gastr... Stage IIB Gastr... Stage IIIA Gast... Stage IIIB Gast... | Carboplatin Computed Tomogr... Fluorouracil Laboratory Biom... Leucovorin Calc... Oxaliplatin Paclitaxel Pembrolizumab Positron Emissi... Radiation Thera... Therapeutic Con... | 18 Years - 80 Years | Mayo Clinic | |
| SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer | NCT03411070 | Positive Axilla... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... | Implanted Medic... Therapeutic Con... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer | NCT00610740 | Cervical Cancer Endometrial Can... Ovarian Cancer | topical gemcita... therapeutic con... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer | NCT01718223 | Recurrent Squam... Recurrent Squam... Recurrent Verru... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage II Squamo... Stage II Squamo... Stage II Verruc... Tongue Cancer | photodynamic th... therapeutic con... laboratory biom... temoporfin | 18 Years - | Roswell Park Cancer Institute | |
| Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer | NCT00016276 | Cardiac Toxicit... Inflammatory Br... Stage IIIA Brea... Stage IIIB Brea... Stage IV Breast... | dexrazoxane hyd... doxorubicin hyd... cyclophosphamid... paclitaxel trastuzumab therapeutic con... radiation thera... tamoxifen citra... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus | NCT00002706 | Endometrial Ade... Stage I Uterine... Stage I Uterine... Stage II Uterin... Stage II Uterin... | Laparoscopic Su... Quality-of-Life... Therapeutic Con... | 18 Years - | GOG Foundation | |
| Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck | NCT00720304 | Head and Neck C... | docetaxel erlotinib hydro... fluorescence in... polymerase chai... immunoenzyme te... immunohistochem... laboratory biom... pharmacological... therapeutic con... intensity-modul... radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer | NCT00052559 | Adenocarcinoma ... Stage II Rectal... Stage III Recta... | bevacizumab fluorouracil external beam r... therapeutic con... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer | NCT00625625 | Colorectal Canc... | isosulfan blue polymerase chai... diagnostic labo... immunohistochem... diagnostic lymp... therapeutic con... therapeutic lym... | 18 Years - | National Cancer Institute (NCI) | |
| Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery | NCT00977457 | Prostate Cancer | DNA analysis DNA methylation... RNA analysis gene expression... polymerase chai... diagnostic labo... therapeutic con... | 18 Years - | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
